Birdshot retinochoroidopathy: Immunopathogenesis, evaluation, and treatment

Ophthalmology Clinics of North America

Volumn 15, Issue 3, 2002, Pages 343-350

  Levinson, Ralph D ^a   Gonzales, Christine R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HLA 29 ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

CATARACTOGENESIS; CHORIORETINOPATHY; CLINICAL FEATURE; DISEASE ASSOCIATION; DOSE RESPONSE; GLAUCOMA; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; NIGHT BLINDNESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; VISUAL ACUITY; VISUAL IMPAIRMENT;

AUTOIMMUNE DISEASES; CHORIORETINITIS; HLA-A ANTIGENS; HUMANS; UVEITIS, POSTERIOR;

EID: 0036709811     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00031-7     Document Type: Review

References (52)

1. Henderly DE, Genstler AJ, Smith RE, et al. Changing patterns of uveitis. Am J Ophthalmol 1987;103:131-6.
2. Smit RL, Baarsma GS, de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol 1993;17:71-6.
3. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114:593-9.
4. Gasch AT, Smith JA, Whitcup SM. Birdshot retinochoroidopathy. Br J Ophthalmol 1999;83:241-9.
5. Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: Clinical characteristics and evolution. Br J Ophthalmol 1988;72:646-59.
6. Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol 1980;89:31-45.
7. Bloch-Michel E, Frau E. Birdshot retinochoroidopathy and HLA-A29+ and HLA-A29- idiopathic retinal vasculitis: Comparative study of 56 cases. Can J Ophthalmol 1991;26:361-6.
8. Nussenblatt RB, Gery I, Weiner HL, et al. Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial. Am J Ophthalmol 1997;123:583-92.
9. Soubrane G, Bokobza R, Coscas G. Late developing lesions in birdshot retinochoroidopathy. Am J Ophthalmol 1990;109:204-10.
10. Godel V, Baruch E, Lazar M. Late development of chorioretinal lesions in birdshot retinochoroidopathy. Ann Ophthalmol 1989;21:49-52.
11. Barondes MJ, Fastenberg DM, Schwartz PL, et al. Peripheral retinal neovascularization in birdshot retinochoroidopathy. Ann Ophthalmol 1989;21:306-8.
12. Brucker AJ, Deglin EA, Bene C, et al. Subretinal choroidal neovascularization in birdshot retinochoroidopathy. Am J Ophthalmol 1985;99:40-4.
13. Caballero-Presencia A, Diaz-Guia E, Lopez-Lopez JM. Acute anterior ischemic optic neuropathy in birdshot retinochoroidopathy. Ophthalmologica 1988;196:87-91.
14. Fuerst DJ, Tessler HH, Fishman GA, et al. Birdshot retinochoroidopathy. Arch Ophthalmol 1984;102:214-9.
15. Soubrane G, Coscas G, Binaghi M, et al. Birdshot retinochoroidopathy and subretinal new vessels. Br J Ophthalmol 1983;67:461-7.
16. Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982;94:147-58.
17. Gass JD. Vitiliginous chorioretinitis. Arch Ophthalmol 1981;99:1778-87.
18. Hesse S, Berbis P, Chemila JF, et al. Psoriasis and birdshot chorioretinopathy: Response to aromatic retinoids. Dermatology 1993;187:137-9.
19. Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporine therapy in the treatment of birdshot retinochoroidopathy. Ophthalmology 1994;101:822-31.
20. Wagoner MD, Albert DM, Lerner AB, et al. New observations on vitiligo and ocular disease. Am J Ophthalmol 1983;96:16-26.
21. Heaton JM, Mills RP. Sensorineural hearing loss associated with birdshot retinochoroidopathy. Arch Otolaryngol Head Neck Surg 1993;119:680-1.
22. Noble KG, Greenberg J. Appearance of birdshot retinochoroidopathy in a patient with myelodysplasia syndrome. Am J Ophthalmol 1998;125:108-9.
23. Cunningham Jr. ET, Sabrosa NA, Pavesio CE. Posterior scleritis mimicking birdshot retinochoroidopathy. Eye 2001;15:231-3.
24. Brod RD. Presumed sarcoid choroidopathy mimicking birdshot retinochoroidopathy. Am J Ophthalmol 1990;109:357-8.
25. Kuboshiro T, Yoshioka H. Birdshot retinochoroidopathy: A possible relationship to ocular sarcoidosis. Kurume Med J 1988;35:193-9.
26. Read RW, Rao NA, Sharma OP. Sarcoid choroiditis initially diagnosed as birdshot choroidopathy. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:85-6.
27. Vrabec TR, Augsburger JJ, Fischer DH, et al. Taches de bougie. Ophthalmology 1995;102:1712-21.
28. Hirose T, Katsumi O, Pruett RC, et al. Retinal function in birdshot retinochoroidopathy. Acta Ophthalmol Scand 1991;69:327-37.
29. Kaplan HJ, Aaberg TM. Birdshot retinochoroidopathy. Am J Ophthalmol 1980;90:773-82.
30. Fardeau C, Herbort CP, Kullmann N, et al. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology 1999;106:1928-34.
31. Howe LJ, Stanford MR, Graham EM, et al. Choroidal abnormalities in birdshot chorioretinopathy: An indocyanine green angiography study. Eye 1997;11:554-9.
32. Baarsma GS, Kijlstra A, Oosterhuis JA, et al. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Doc Ophthalmol 1986;61:267-9.
33. Baarsma GS, Priem HA, Kijlstra A. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Curr Eye Res 1990;9:63-8.
34. LeHoang P, Ozdemir N, Benhamou A, et al. HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol 1992;113:33-5.
35. Feltkamp TE. HLA and uveitis. Int Ophthalmol 1990;14:327-33.
36. Feltkamp TE. Ophthalmological significance of HLA associated uveitis. Eye 1990;4:839-44.
37. Tabary T, Lehoang P, Betuel H, et al. Susceptibility to birdshot chorioretinopathy is restricted to the HLA-A29.2 subtype. Tissue Antigens 1990;36:177-9.
38. de Waal LP, Lardy NM, van der Horst AR, et al. HLA-A29 subtypes and birdshot chorioretinopathy. Immunogenetics 1992;35:51-3.
39. Szpak Y, Vieville JC, Tabary T, et al. Spontaneous retinopathy in HLA-A29 transgenic mice. Proc Natl Acad Sci U S A 2001;98:2572-6.
40. Fich M, Rosenberg T. Birdshot retinochoroidopathy in monozygotic twins. Acta Ophthalmol Scand 1992;70:693-7.
41. Jobin D, Thillaye B, de Kozak Y, et al. Severe retinochoroidopathy: Variations of humoral and cellular immunity to S-antigen in a longitudinal study. Curr Eye Res 1990;9:91-6.
42. de Smet MD, Yamamoto JH, Mochizuki M, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990;110:135-42.
43. Boisgerault F, Khalil I, Tieng V, et al. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc Natl Acad Sci U S A 1996;93:3466-70.
44. Marsh SGE, Parham P, Barber LD. The HLA Facts Book. San Diego: Academic Press; 2000.
45. Suttorp-Schulten MS, Luyendijk L, van Dam AP, et al. Birdshot chorioretinopathy and Lyme borreliosis. Am J Ophthalmol 1993;115:149-53.
46. Kuhne F, Morlat P, Riss I, et al. [Is A29, B12 vasculitis caused by the Q fever agent? (Coxiella burnetii)]. J Fr Ophtalmol 1992;15:315-21.
47. Schlaegel Jr. TF, Kao SF. A review (1970-1980) of 28 presumptive cases of syphilitic uveitis. Am J Ophthalmol 1982;2:412-4.
48. Koetz K, Bryl E, Spickschen K, et al. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000;97:9203-8.
49. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol 2000;130:492-513.
50. Ladas JG, Arnold AC, Holland GN. Control of visual symptoms in two men with birdshot retinochoroidopathy using low-dose oral corticosteroid therapy. Am J Ophthalmol 1999;128:116-8.
51. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001;119:1380-3.
52. LeHoang P, Cassoux N, George F, et al. Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy. Ocul Immunol Inflamm 2000;8:49-57.